L'Office européen de
L'Office européen des brevets notifie Bioxodes de son intention de délivrer un brevet offrant une large protection à son actif principal dans le traitement des thrombo-inflammations
May 16, 2024 03:04 ET | Bioxodes
Gosselies (Belgique), le 16 mai 2024 – Bioxodes SA, société biopharmaceutique de stade clinique développant de nouvelles thérapies dédiées à la prévention et au traitement de maladies thrombotiques et...
Bioxodes-Logo_Fond transparent.png
Bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protection in thromboinflammation
May 16, 2024 03:04 ET | Bioxodes
Gosselies (Belgium), May 16, 2024 – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases,...
UMeWorld to Debut the World's First & Only Weight Loss Cooking Oil in the US
April 09, 2024 08:00 ET | UMeWorld Limited
MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is excited to announce that the company has secured an exclusive license to use proprietary enzymatic technologies to...
RapidPulse Logo - Gradient w Slogan Small.png
Study Investigators Conclude RapidPulse™ Precise Cyclic Aspiration Is Highly Effective and Safe for Ischemic Stroke Large Vessel Occlusions
April 04, 2024 09:04 ET | RapidPulse, Inc
Study Investigators Conclude RapidPulse™ Precise Cyclic Aspiration Is Highly Effective and Safe for Ischemic Stroke Large Vessel Occlusions
Astrocyte Logo.png
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
March 12, 2024 12:00 ET | Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
Product image
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
February 21, 2024 08:00 ET | Route 92 Medical, Inc.
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
22157.jpg
Stroke Rehabilitation Industry Poised for Growth as Innovations in Virtual Reality and Tele-Rehabilitation Advance
January 31, 2024 10:33 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Stroke Rehabilitation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
22157.jpg
Stroke Management Market Poised to Surge from $36.94 Billion to $39.98 Billion in 2024
January 28, 2024 19:56 ET | Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Stroke Management Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global landscape of stroke management...
R-Rt92-logo-rbg0.png
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
November 16, 2023 09:00 ET | Route 92 Medical, Inc.
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
R-Rt92-logo-rbg0.png
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
November 14, 2023 09:00 ET | Route 92 Medical, Inc.
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.